Related Experiment Videos
Melanoma in pregnancy.
1Department of Obstetrics and Gynecology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL.
Clinical Obstetrics and Gynecology
|December 1, 1990
Summary
Malignant melanoma in pregnancy has a similar clinical course to non-pregnant patients. Early detection and treatment of melanoma are key for an excellent prognosis, and maternal-infant transmission is rare.
Area of Science:
- Oncology
- Obstetrics & Gynecology
- Dermatology
Background:
- The clinical course of malignant melanoma during pregnancy has been debated.
- Current evidence suggests pregnancy does not alter melanoma's clinical behavior.
Purpose of the Study:
- To review the clinical course, management, and prognosis of malignant melanoma in pregnant patients.
- To highlight the role of obstetrician-gynecologists in early detection.
Main Methods:
- Review of current literature on malignant melanoma in pregnancy.
- Analysis of clinical outcomes, treatment strategies, and prognostic factors.
Main Results:
- Malignant melanoma in pregnancy follows a course similar to that in non-pregnant individuals.
- Early detection and surgical excision are critical for favorable prognosis.
- Maternal-to-fetal or placental metastasis is rare.
- Most recurrences occur within 3 years post-diagnosis.
Conclusions:
- Obstetrician-gynecologists play a vital role in the early detection of melanoma in women of reproductive age.
- Elective termination is not warranted due to maternal melanoma diagnosis.
- Post-treatment follow-up is essential, and subsequent pregnancies should be deferred for at least 3 years.